Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,538 | -23,631 | -116,537 | -86,438 | -76,532 |
| Depreciation Amortization | N/A | N/A | 374 | 280 | 89 |
| Accounts payable and accrued liabilities | 2,244 | 451 | -2,600 | N/A | -1,603 |
| Other Working Capital | 3,425 | 265 | -4,917 | -4,232 | -984 |
| Other Operating Activity | 46,354 | 14,174 | 84,153 | 59,994 | 60,885 |
| Operating Cash Flow | $-16,515 | $-8,741 | $-39,527 | $-30,396 | $-18,145 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,130 | 9,783 | -45,287 | -55,363 | -30,334 |
| Investing Cash Flow | $-10,130 | $9,783 | $-45,287 | $-55,363 | $-30,334 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 48,072 | 1 | 33,017 | 33,017 | 33,017 |
| Financing Cash Flow | $48,072 | $1 | $33,017 | $33,017 | $33,017 |
| Beginning Cash Position | 4,612 | 4,612 | 56,409 | 56,409 | 56,409 |
| End Cash Position | 26,039 | 5,655 | 4,612 | 3,667 | 40,947 |
| Net Cash Flow | $21,427 | $1,043 | $-51,797 | $-52,742 | $-15,462 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,515 | -8,741 | -39,527 | -30,396 | -18,145 |
| Free Cash Flow | -16,515 | -8,741 | -39,527 | -30,396 | -18,145 |